Feed ANIK
AN
Anika Therapeutics, Inc. ANIK · NASDAQ
$21.27 -0.70% (-$0.15)
Depth
- Market cap
- $284.7M
- Enterprise value
- $269.6M
- P/E
- -
- Forward P/E
- 18.9x
- PEG
- -
- P/S
- 2.4x
- P/FCF
- 506.5x
- EV/EBITDA
- 99.2x
- ROIC
- -3.4%
- Gross margin
- 62.2%
- Net margin
- -3.1%
- Dividend yield
- -
- Payout ratio
- -
- Net debt/EBITDA
- -5.6x
- Beta
- 0.21
- Free float
- 93.7%
Sector
Healthcare
Industry
Medical - Specialties
CEO
Stephen D. Griffin
Employees
235
Headquarters
Bedford
Valuation
Is today's price reasonable?
- What to watch: The share price is above the Bulios Fair Price.
Growth and estimates
Is it growing, and what comes next?
Profitability and quality
How much of the revenue is left, and how well does the company use its capital?
- What to watch: The company made a loss over the last 12 months.
Financial health
Can it carry its debt?
- What speaks for it: It holds more cash than debt: $38.4M against $23.3M.
Capital and dividends
What does the company do with the money it earns?
- What speaks for it: It bought back its own shares for $9.49M in the last fiscal year, 3.3% of its market value.
Analysts
What do the professionals think, and is it changing?
Owners and insiders
Who holds the stock, and what is management doing?
Segments
Which part of the company is growing?
Peer comparison
How does it compare with similar companies?
Price and risk
How does the stock behave?
Statements
Every number